Allscripts announces first quarter 2018 results

Go back to Allscripts announces first quarter 2018 results

Allscripts (MDRX) PT Lowered to $14.50 at RBC Capital

May 4, 2018 8:20 AM UTC

RBC Capital lowered its price target on Allscripts (NASDAQ: MDRX) to $14.50 (from $17.00) while maintaining a Outperform rating.

... More

Allscripts (MDRX) PT Lowered to $13 at Evercore ISI

May 4, 2018 7:44 AM UTC

Evercore ISI lowered its price target on Allscripts (NASDAQ: MDRX) to $13.00 (from $14.00) while maintaining a Outperform rating.

... More

Allscripts (MDRX) Misses Q1 EPS by 1c, Affirms Outlook

May 3, 2018 4:04 PM UTC

Allscripts (NASDAQ: MDRX) reported Q1 EPS of $0.16, $0.01 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $518.6 million versus the consensus estimate of $530.48 million.

Allscripts affirms the following financial outlook for 2018

For earnings history and earnings-related data on Allscripts (MDRX) click here.

... More